Tag: restasis
And then there were three.
We've got a new dry eye med to prescribe. The FDA just approved Cequa ("see-qwa"), a prescription eye drop indicated to increase tear production in patients...
Looks like a Restasis generic is on the way.
Remember last year when Allergan thought of a really creative way to hold on to their Restasis patents?
If not, here is your 30 second...
What your patient might ask you…
What other prescription options do I have to treat my dry eye?
You may start hearing about CyclASol, another dry eye medication currently in clinical trials....
What your patient might ask you…
Is there a generic for Restasis?
Not yet, but there might be a workaround. The pharmaceutical company, Imprimis, has announced they will be making compounded cyclosporin as a...
Xiidra and Restasis are in a fight.
Shire (maker of Xiidra) is suing Allergan (maker of Restasis).
Why?
Shire says that Allergan has blocked access to Xiidra for patients with Part D Medicare...
Allergan transfers the patents for Restasis to a Native American tribe.
In an unprecedented attempt by a pharmaceutical company to hold on to their patents, Allergan has initiated a deal to transfer the patents for...
If you prescribe Restasis…
Restasis Multidose is now available in the US.  It is same preservative-free Restasis formulation, but now in a multidose bottle.
Two drugs announced positive phase three results last week.
1.  Dextenza - some results were released back in November (20/20 Glance recap here) but they recently announced they also met their secondary endpoint.
What is Dextenza?
It's a dexamethasone...